Related Experiment Video
Updated: Jul 14, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Pharmacogenetics and asthma: false hope or new dawn?
1Division of Therapeutics and Molecular Medicine, University Hospital of Nottingham, Nottingham, NG7 2UH, UK. ian.hall@nottingham.ac.uk
The European Respiratory Journal
|June 2, 2007
Summary
Pharmacogenetics can optimize asthma drug prescribing by understanding genetic variations. Further research is needed on gene polymorphism consequences and clinical study design for better efficacy and fewer side effects.
Area of Science:
- Pharmacogenetics
- Genomics
- Clinical Pharmacology
Background:
- Genetic variations influence drug response in asthma patients.
- Comprehensive genomic data exists, but functional consequences of polymorphisms are often unknown.
- Current knowledge gaps hinder personalized asthma treatment optimization.
Purpose of the Study:
- To review the current state of pharmacogenetic knowledge in asthma.
- To identify areas requiring further research for improved asthma pharmacotherapy.
- To bridge the gap between genetic discoveries and clinical application.
Main Methods:
- Review of existing literature on pharmacogenetics in asthma.
- Analysis of genetic variation data and its functional implications.
- Assessment of the quality and power of current clinical studies.
Main Results:
- Significant genetic variation data is available for asthma pharmacogenetics.
- Functional consequences of many gene polymorphisms affecting drug efficacy remain unclear.
- A shortage of well-designed, adequately powered clinical studies exists.
Conclusions:
- Pharmacogenetic approaches hold promise for optimizing asthma medication efficacy and safety.
- Further research into the functional impact of genetic polymorphisms is crucial.
- Enhanced clinical study designs are necessary to validate pharmacogenetic findings in asthma.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...